Podcasts about mounjaro

Could medications originally designed for diabetes actually help treat addiction, eating disorders, and the biology of cravings?In this part 2 of 2-part episode of Succeed In Medicine Podcast, Dr. Bradley Block sits down with Dr. Sean Wharton, to dig deeper into the science, myths, and emerging uses of GLP-1 agonists. Dr. Wharton explains that these medications don't simply reduce appetite, they calm what he calls “food noise,” the constant mental pull toward eating that many people with obesity experience. This neurological effect has opened the door to exciting possibilities: early research suggests GLP-1 drugs may also reduce cravings for alcohol and other addictive behaviors.  Dr. Wharton also clarifies the confusing world of brand names. Ozempic and Wegovy are both semaglutide; Mounjaro and Zepbound are tirzepatide. The differences are largely about FDA indications and insurance coverage, not completely different medications.The episode tackles common fears patients and clinicians hear every day. Do these medications cause eating disorders? No, in fact, they may help treat them. Are the side effects dangerous? Usually not, and most are manageable with proper dosing. Is “Ozempic face” real? It's simply normal fat loss, not a drug-specific problem. Most importantly, Dr. Wharton reinforces a compassionate, evidence-based message: obesity is a chronic, biological disease, and GLP-1 medications are tools to treat it, just like medications for blood pressure or diabetes.Three Actionable TakeawaysGLP-1 Medications Affect the Brain as Much as the Stomach: These drugs reduce “food noise” and cravings, helping patients regain control over eating behaviors. Their impact is neurological, not simply about willpower or restriction.Side Effects Are Real—but Usually Manageable: Nausea, constipation, and GI symptoms are the most common issues, especially early on. Starting low and increasing doses slowly makes treatment far more tolerable.Treatment Decisions Should Be Individualized:  Not every patient must stay on these medications forever. Conversations about duration, goals, and expectations should be collaborative and tailored to each person.About the Show:Succeed In Medicine covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school!About the Guest:Dr. Sean Wharton holds doctorates in Pharmacy and Medicine from the University of Toronto. He is the Director of the Wharton Medical Clinic, a community-based weight management and diabetes clinic, and serves as Assistant Professor at the University of Toronto and Adjunct Professor at McMaster and York Universities.Dr. Wharton is the lead author of the 2020 Canadian Obesity Guidelines, recognized worldwide, and has published extensively in major medical journals including the New England Journal of Medicine. He is a passionate advocate for health equity and improving the way obesity is understood and treated in healthcare.LinkedIn: linkedin.com/in/drseanwhartonWebsite: whartonmedicalclinic.comAbout the Host:Dr. Bradley Block – Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts Succeed In Medicine podcast, focusing on personal and professional development for physiciansWant to be a guest?Email Brad at brad@physiciansguidetodoctoring.com  or visit www.physiciansguidetodoctoring.com to learn more!Socials:@physiciansguidetodoctoring on Facebook@physicianguidetodoctoring on YouTube@physiciansguide on Instagram and Twitter  This medical podcast is your physician mentor to fill the gaps in your medical education. We cover physician soft skills, charting, interpersonal skills, doctor finance, doctor mental health, medical decisions, physician parenting, physician executive skills, navigating your doctor career, and medical professional development. This is critical CME for physicians, but without the credits (yet). A proud founding member of the Doctor Podcast Network!Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Send us a textCan Zepbound treat PCOS? That's the question this clinical trial will seek to answer, and we cover it exclusively on this week's On The Pen podcast.Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!

Discover the truth about GLP-1 medications like Ozempic and Mounjaro as we debunk five major myths. Learn why these aren't just medications, the critical role of exercise, long-term use concerns, dietary requirements, and natural alternatives like Berberine that support your body's own GLP-1 production for sustainable weight loss and blood sugar management. FEATURED PRODUCT The Good Poops Protocol is your foundation for naturally supporting GLP-1 production while addressing the root cause—your gut health. This powerful combination featuring Berberine Plus, Gut Powder, and Liver Boost works synergistically to support blood sugar control, healthy digestion, and sustainable weight loss. While GLP-1 medications address symptoms, the Good Poops Protocol helps your body create its own GLP-1s naturally, supports metabolic function, and protects your liver and gallbladder during weight loss—without the long-term medication dependency.

We are rebranding from Game-Changing Health to Your GLP-1 Bestie- stay tuned!

I'm sharing something deeply personal. January is often filled with talk of fresh starts and motivation — but real life doesn't always follow that script. Over the last few weeks, my family has been living through the realities of dementia, loss, and grief, and I wanted to speak honestly about what that has meant for my health, my mindset, and my relationship with food. This episode isn't about perfection. It's about compassion, steadiness, and choosing not to abandon yourself when life feels overwhelming. In this episode, I talk about: Living through dementia and the loss of my dad The emotional weight of care, advocacy, and grief Why binge eating didn't return — even during intense stress Letting go of shame around weight gain Gentle, realistic intentions instead of pressure How creativity  supports me right now Why health still matters — even (and especially) in grief If you've experienced dementia, loss, or a season where everything feels heavier than usual, I hope this episode helps you feel less alone. This podcast is free of editing because in life sometimes we have to take the rough with the smooth and not be afraid to show our messy parts.  Get the first 3 modules of “Ease Your Mind” mini-course now for FREE https://www.claireoldhamwest.com/Ease-your-mind

Are today's diabetes medications actually treating the disease, or just managing symptoms? In this episode, renowned diabetes educator Gary Scheiner breaks down the fast-growing world of GLP-1 drugs like Ozempic and Mounjaro – explaining what they do, who they're for, and why they're so effective… As the owner and clinical director of Integrated Diabetes Services, Gary has devoted his career to improving the lives of people with insulin-dependent diabetes. Living with type 1 diabetes since 1985, he is an award-winning Certified Diabetes Care and Education Specialist, a master's-level exercise physiologist, and was named 2014 Diabetes Educator of the Year by the American Association of Diabetes Educators. He's also the author of several foundational books, including Think Like a Pancreas, Get Control of Your Blood Sugar, and The Ultimate Guide to Accurate Carb Counting, and is a frequent speaker at national and international diabetes conferences. Jump in now to find out: The importance of finding a healthy balance when managing diabetes. What makes GLP-1 medications unique.  How diabetes impacts food digestion. What elevated glucose levels do to the rest of the body. To keep up with Gary and his work, follow him on LinkedIn!

Dr. Meg Mill, a clinical pharmacist and functional medicine practitioner, joins Dr. Whitfield for a deep dive into the chronic inflammatory conditions he sees daily in his practice. She explains how mast cell activation syndrome develops when your immune system becomes overwhelmed and starts misfiring, reacting to everything from food to water to air. The conversation takes an unexpected turn into GLP-1 drugs like Ozempic and Mounjaro, where Dr. Whitfield shares his clinical concerns about young, lean women using these powerful medications without understanding the consequences. From his surgical perspective, he's watching patients burn their facial fat and age dramatically while chasing unrealistic body standards promoted by online influencers. Dr. Mill reinforces that real healing requires nervous system work, not just another supplement or drug, and both doctors emphasize the danger of buying compounded medications online when you have no idea what's actually in them. Learn more about Dr. Meg Mill: Dr. Mill's podcast: A Little Bit Healthier: https://megmill.com/podcasts/ Dr. Mill's Newsletters: https://megmill.com/newsletters/  IN THIS EPISODE WE'LL: Learn why nervous system work is the foundation that has to come before supplements, medications, or any other intervention can actually help you heal Transform your understanding of GLP-1 drugs and why microdosing isn't the magic solution influencers want you to believe it is Discover why your immune system starts reacting to safe things like water and how nervous system dysregulation creates these misfiring patterns Break through the confusion around mast cell activation syndrome and learn what's actually triggering your body to stay in constant inflammatory overdrive Uncover the truth about facial aging and why burning fat in your face makes you look older faster than almost anything else CHECK OUT THESE EPISODES: How to Fix Leaky Gut & Reverse Chronic Inflammation with Dr. Tom O'Bryan The Real Causes of Autoimmunity in Women with Dr. Sara Szal Links and Resources Let's Connect Podcast: https://podcasts.apple.com/gb/podcast/breast-implant-illness/id1678143554 YouTube: https://www.youtube.com/@robertwhitfieldmd/videos Spotify: https://open.spotify.com/show/1SPDripbluZKYsC0rwrBdb?si=23ea2cd9f6734667 TikTok: https://www.tiktok.com/@drrobertwhitfield?_t=8oQyjO25X5i&_r=1 IG: https://www.instagram.com/breastimplantillnessexpert/ FB: https://www.facebook.com/DrRobertWhitfield Linkedin: https://www.linkedin.com/in/dr-robert-whitfield-md-50775b10/ X: https://x.com/rob_whitfieldmd Read this article - https://www.breastcancer.org/treatment/surgery/breast-reconstruction/types/implant-reconstruction/illness/breast-implant-illness Shop: https://drrobssolutions.com SHARP: https://www.harp.health NVISN Labs - https://nvisnlabs.com/ Get access to Dr. Rob's Favorite Products below: Danger Coffee - Use our link for mold free coffee - https://dangercoffee.com/pages/mold-free-coffee?ref=ztvhyjg JASPR Air Purifier - Use code DRROB for the Jaspr Air Purifier - https://jaspr.co/ Echo Water - Get high quality water with our code DRROB10 - https://echowater.com/ BallancerPro - Use code DRROBVIP for the world's leader in lymphatic drainage technology - https://ballancerpro.com Ultrahuman - Use code WHITFIELD10 for the most accurate wearable - https://www.ultrahuman.com/ring/buy/us/?affiliateCode=drwhitfield

I recently read something that stopped me in my tracks: being fat robbed me of my femininity.And I haven't been able to shake it.In this episode, I pose a question that came out of a Reddit thread but really speaks to a shared experience so many of us quietly lived: growing up, did femininity ever feel like it wasn't meant for you?I'm sharing my own experiences of being invisible next to friends, being talked about like I wasn't even a person, not being able to shop where other girls shopped, missing out on certain “girlhood” moments, and learning very early on which bodies were allowed to be soft, desired, and feminine and which weren't.We'll talk about how those moments shape us long after childhood, how confidence can coexist with old wounds, and what it actually looks like to take your femininity back without performing it or earning permission.If you've ever felt like girlhood passed you by, or like femininity came with conditions you didn't meet, this episode is for you. You're not alone—and you didn't imagine it.Show Notes!

Ozempic and other GLP-1 medications aren't just changing bodies. They're changing brains too. In this episode, I unpack what's really happening beneath the surface when you take medications like Ozempic, Wegovy, or Mounjaro. Not from a place of hype or fear-mongering, but from curiosity, neuroscience, and compassion. We talk about how GLP-1s influence hunger, motivation, emotional balance, and even your sense of self, and why so many people are surprised by the mental and emotional shifts that come along with physical weight loss. You'll learn: How GLP-1s interact with dopamine and reward pathways in the brain Why some people experience emotional blunting, reduced motivation, or changes in desire What actually happens when you stop taking them, and why hunger returning isn't failure, weakness, or a lack of discipline The neuroscience behind craving, self-control, and identity What hunger really does for emotional regulation and psychological resilience And just as important, this isn't an episode telling you what you should do. Whether a GLP-1 medication is right for you is a deeply personal decision, one that only you and your doctor can make together based on your body, your health history, and your life. There is no moral hierarchy here. Using a GLP-1 is not cheating, not taking shortcuts, and not something that requires justification or shame. This conversation is about understanding what these medications do to the brain so you can make informed, self-respecting choices, whatever those choices end up being. If this message resonates with you, like, comment, subscribe, and share to help more people understand how the brain and body really connect. ⚡️If you want to go deeper, Join my annual 21-Day Brain Detox Challenge: reset your mind, break toxic thought cycles, and build real mental resilience—$50 off + a FREE surprise gift from Dr. Leaf with code WELCOME50! Register here: https://21daybraindetox.com

Send us a textIn this episode of On The Pen: The Weekly Dose, Dave Knapp breaks down why the idea of over-the-counter GLP-1 medications isn't radical speculation, it's a pattern already in motion. Drawing on FDA signals, past regulatory precedent with Orlistat, recent pricing negotiations, softened safety language, and public comments from pharmaceutical executives, Dave lays out the case that low-dose oral GLP-1s could be the first step toward OTC access. This episode connects the dots between regulation, access, pricing, and normalization of obesity treatment, and explains why the people laughing today may be asking how they missed it tomorrow.

En este episodio junto al Dr. Jorge García entramos de lleno en las grandes contradicciones de la salud moderna.Hablamos de los aciertos y desaciertos de MAHA (Make America Healthy Again) y de cómo muchos discursos bien intencionados terminan chocando con la biología real. Analizamos las contradicciones de la nueva pirámide nutricional.Entramos a fondo en los fármacos GLP-1 como Ozempic y Mounjaro: qué hacen, qué no hacen, para quiénes pueden tener sentido y todo lo que esta en desarrollo.También hablamos de optimización hormonal en hombres y mujeres, por qué requiere precisión y criterio, por qué no recomendamos el uso de pellets hormonales y cuales son las mejores practicas que prometen mayor efectividad y menor riesgo.Abordamos la longevidad desde lo fundamental, con el sueño como pilar no negociable, y cerramos con una verdad incómoda que muchos evitan:para ganar y retener masa muscular no basta con comer proteína; se necesita tensión mecánica real, entrenamiento con pesas y estímulo suficiente.

Send us a textShantanu Gaur, CEO of Allurion, returns to the podcast to break down their swallowable inflatable weight loss balloon, how it works, who it is for, how much it is expected to cost, and when patients can realistically expect access.We talk real world weight loss results, safety, availability in the US, and how Allurion fits into the broader obesity treatment conversation alongside GLP-1 medications and bariatric options.This is a clear, no hype discussion for patients who want more tools and better choices in obesity care.More Info:OTPLinks.com

Sponsor Link:This episode of SpaceTime is brought to you with the support of Squarespace. When it's time to get a presence online, go with the folks who support us...and build the best websites easily. No hassles. You can check out their special offer for SpaceTime listeners by visiting our special URL....Click HereSpaceTime with Stuart Gary Gary - Series 29 Episode 7In this episode of SpaceTime, we delve into the intriguing possibilities surrounding the origins of life, including new findings from Saturn's moon Titan and the implications for our understanding of life beyond Earth. We also explore the latest research on Europa, one of Jupiter's moons, and uncover the sources of the sun's mysterious gamma rays.Life's Building Blocks on TitanA groundbreaking study reveals that Titan, Saturn's largest moon, exhibits unexpected chemical interactions at extremely low temperatures. Researchers found that hydrogen cyanide can mix with nonpolar substances like methane and ethane, challenging traditional chemistry principles. This discovery could provide insights into the prebiotic chemistry that may have preceded life on Earth, as Titan's environment mirrors that of early Earth.Europa's Quiet OceansIn a surprising turn, new calculations suggest that the vast subsurface ocean beneath Europa's icy crust may be lifeless. This research indicates that Europa lacks the geological activity, such as hydrothermal vents, necessary to sustain life. Lead author Paul Brian discusses how the moon's stable orbit around Jupiter limits the tidal forces that could drive geological processes, casting doubt on the moon's potential as a habitat for life.The Source of Solar Gamma RaysAstronomers have identified the origin of intense gamma radiation emitted during solar flares, linking it to high-energy electrons colliding with plasma in the solar corona. This finding, derived from observations of a significant solar flare in 2017, enhances our understanding of solar flare physics and could improve space weather forecasting.www.spacetimewithstuartgary.com✍️ Episode ReferencesJournal of the Proceedings of the National Academy of SciencesNature CommunicationsNature AstronomyBecome a supporter of this podcast: https://www.spreaker.com/podcast/spacetime-your-guide-to-space-astronomy--2458531/support.(00:00:00) Scientists studying Saturn's moon Titan have discovered that normally incompatible substances can mix(00:05:19) NASA will launch the Dragonfly mission to Titan in 2028(00:13:36) NASA's Europa Clipper spacecraft will study icy moon Europa(00:18:11) Astronomers have discovered that gamma rays generated by solar flares are caused by electrons(00:21:58) Most people who take diabetes drug Mounjaro gain weight back after stopping

HEALTH NEWS   Probiotics emerge as a potent tool against depression and anxiety Altered microbiome: Oral bacteria play a role in chronic liver disease, study reveals Health issues linked to cosmetic jab complications From yoga to awe walks: Many paths lead to better mental health, largest analysis of well-being interventions finds Weight loss drugs may cause nutritional deficiencies without proper guidanc       Probiotics emerge as a potent tool against depression and anxiety University of Calgary (Canada), January 14 2026 (Natural News) For decades, the standard pharmaceutical approach to treating depression and anxiety has dominated treatment options, despite significant drawbacks including delayed effects, debilitating side effects and high relapse rates. Now, compelling new research is challenging this paradigm by pointing to a surprising source of relief: the gut. A comprehensive scientific analysis, synthesizing data from over 1,400 clinically diagnosed patients, reveals that probiotics—beneficial bacteria readily available as supplements—can produce substantial reductions in both depressive and anxious symptoms.   The analysis major findings include:     A major analysis of 23 clinical trials finds probiotics can significantly reduce symptoms of depression and anxiety in clinically diagnosed patients.   The benefits, appearing within 4-8 weeks, were comparable to some conventional antidepressants but without the same side-effect profile.   The gut-brain axis, a communication network largely ignored by conventional psychiatry, is central to understanding this connection.   Single-strain probiotic supplements, particularly certain Lactobacillus and Bifidobacterium species, showed the strongest mental health effects.   This research supports a holistic view of mental wellness, where gut health is a foundational component of treatment.     Altered microbiome: Oral bacteria play a role in chronic liver disease, study reveals Technical University Munich (Germany), January 15 2026 (Medical Xpress) Each year, more than two million people die from advanced chronic liver disease (ACLD). Previous research has linked gut microbiome disruptions to this condition and suggested that bacteria typically found in the mouth may colonize the gut. A new study published in Nature Microbiology now shows that identical bacterial strains occur in both the mouth and gut of patients with advanced chronic liver disease and also reveals a mechanism by which oral bacteria affect gut health. The researchers also found that this process coincides with worsening liver health. Researchers analyzed bacterial populations in saliva and stool samples from patients. The team found that both the gut and oral microbiome undergo significant changes as liver disease worsened, where changes to the oral microbiome were already detectable at earlier disease stages. In healthy individuals, bacterial communities differ substantially between body sites. In patients with liver disease, however, oral and gut microbiomes became increasingly similar as the disease progressed and nearly identical bacterial strains were recovered from the mouth and gut of patients. "These strains are typically found in the mouth and are rarely present in the healthy gut. However, we observed increases in the absolute abundances of these oral bacteria in patients with advanced chronic liver disease. This strongly suggests that these bacteria translocate from the mouth and colonize the gut," explains Melanie Schirmer, Professor of Translational Microbiome Data Integration at TUM.   Health issues linked to cosmetic jab complications Anglia Ruskin University (UK), January 9 2026 (Eurekalert)   Patients with chronic illnesses face a significantly higher risk of complications from cosmetic botulinum toxin injections, commonly known as Botox, according to a major UK study. Researchers from Anglia Ruskin University (ARU) surveyed 919 adults who had received botulinum toxin treatments for aesthetic reasons. The study, published in Aesthetic Surgery Journal, is the largest of its kind to have been carried out in the UK. Botulinum toxin injections are among the UK's most popular cosmetic procedures, with an estimated 900,000 treatments performed every year. Researchers found that underlying conditions such as type 1 diabetes, thyroid disorders, chronic migraine and skin disease dramatically increase the likelihood of adverse effects. According to the study, people with type 1 diabetes were 92 times more likely to experience nausea after treatment compared to those without the condition. Those with thyroid disorders and chronic migraine sufferers had an approximately 10-fold increase in the risk of nausea. Other complications associated with pre-existing conditions included headaches, bruising, muscle weakness and persistent eyelid droop (ptosis). Patients with cataracts were 30 times more likely to report headaches, and those with prior injuries had a 21-fold increased risk of losing facial expression.   From yoga to awe walks: Many paths lead to better mental health, largest analysis of well-being interventions finds Swansea University (UK), January 15 2026 (Medical Xpress) New research by Swansea experts has provided the largest ever comparison of well-being-focused interventions delivered to adults. The team reviewed 183 randomized controlled trials, representing almost 23,000 participants, and evaluated 12 categories of interventions ranging from psychological, physical, mind–body, and nature-based approaches to find out more. Their research was the first interdisciplinary comparison carried out across psychological, physical, mind-body and environmental interventions. The study gives an integrated view of how different disciplines contribute to well-being. By focusing on general adult samples rather than clinical groups, it provides evidence that will be relevant to developing public health, education, workplace well-being, and community programs. The researchers' key findings were: Most interventions improved well-being compared with inactive control groups; Strongest effects were found for combined exercise plus psychological interventions (for example, awe walks or meditation combined with walking); Mind–body interventions showed consistently moderate, reliable effects; Exercise alone produced similar benefits to many psychological interventions; and, Positive psychology interventions—both single-component and multicomponent—were also effective. The analysis shows that there is no single route to improving well-being. Mindfulness, compassion-based approaches, yoga, exercise and positive psychology interventions all showed moderate benefits compared with control groups, and combining physical activity with psychological interventions appeared particularly promising.   Weight loss drugs may cause nutritional deficiencies without proper guidance     University College London & Cambridge, January 7 2026 (News-Medical) People prescribed the new generation of weight loss drugs may not receive sufficient nutritional guidance to support safe and sustainable weight loss, leaving them vulnerable to nutritional deficiencies and muscle loss, say experts at UCL and the University of Cambridge. In research published today in Obesity Reviews, the team found a lack of robust evidence surrounding nutritional advice and support and the impact this has on factors such as calorie intake, body composition, protein adequacy, and patient experiences. Weight loss drugs such as semaglutide and tirzepatide – available under brand names including Ozempic, Wegovy and Mounjaro – mimic the naturally-occurring hormone glucagon like peptide-1 (GLP-1), released into the blood in response to eating. The drugs suppress appetite, increase a feeling of being full, and reduce food cravings. These drugs can reduce calorie intake by between 16-39 %, making them a powerful tool to help people living with obesity and being overweight. However, there has been little research to examine their impact on diet quality, protein intake, or adequacy of micronutrients (vitamins and minerals). The researchers identified just 12 studies that looked at nutrition and diet alongside treatment with semaglutide or tirzepatide. Given the widespread – and increasing – use of these medications and the urgency of providing advice to individuals using the drugs, there was insufficient evidence from the studies to recommend strict low-fat diets to complement the weight loss drugs. Some observational studies found that people on the treatments often consumed excessive levels of total and saturated fat. These medications are transforming obesity care, but we know very little about how they shape people's daily lives, including changes in appetite, eating patterns, wellbeing, and quality of life.

"Se você tem um martelo na mão, todo problema parece prego." No episódio de hoje do Rapidinhas da Bela, mergulhamos na nova polêmica do wellness: usar análogos de GLP-1 (como Ozempic e Mounjaro) para "desinflamar" doenças autoimunes como Hashimoto e Lúpus, mesmo sem precisar perder peso. Será que a ciência sustenta isso ou estamos criando um novo problema?Eu analiso a fundo a relação entre gordura e inflamação, o potencial promissor desses medicamentos, mas principalmente o risco real de causar um estresse metabólico que o seu corpo não aguenta. Falamos também sobre o elo perdido no tratamento das autoimunes: o seu sistema nervoso e a percepção de segurança celular. Um episódio curto, direto e essencial para quem busca saúde além da estética.Neste episódio, você vai aprender:A diferença entre desinflamar por emagrecer vs. efeito direto do remédio.O risco do "Flare": por que mudanças bruscas podem disparar uma crise autoimune.Por que não devemos usar "um canhão para matar uma formiga".A conexão vital entre sistema nervoso esgotado e doenças autoimunes.O papel do campo energético e emocional na cura real.Meu livro Perimeno Quê? O manual que eu queria ter tido quando eu passei pela perimenopausa já está disponível para vendas.

Is it ok to stay on weight loss injections?They have been nothing short of a pharmaceutical phenomenon. But for people like listener Lynn who've had huge success on weight loss drugs like Mounjaro, the question now arises about the implications of using them long-term. Could there be a 'maintenance' dose that would potentially allow for use over many years, or even a lifetime? And as scientists study the data, are other benefits emerging that go beyond just losing weight that could burnish their wonder-product reputation?Presenter Greg Foot is joined in the studio by Lynn to hear her story and do a deep-dive into the science alongside Professor of Molecular Neuroendocrinology at the University of Cambridge, Giles Yeo.At Sliced Bread we're hungry for your suggestions so we can keep making fresh batches! If you've seen an ad, trend or wonder product promising to make you happier, healthier or greener, email us at sliced.bread@bbc.co.uk OR send a voice note to our WhatsApp number, 07543 306807.RESEARCHER: PHIL SANSOM PRODUCERS: SIMON HOBAN AND GREG FOOT

Is it ok to stay on weight loss injections?They have been nothing short of a pharmaceutical phenomenon. But for people like listener Lynn who've had huge success on weight loss drugs like Mounjaro, the question now arises about the implications of using them long-term. Could there be a 'maintenance' dose that would potentially allow for use over many years, or even a lifetime? And as scientists study the data, are other benefits emerging that go beyond just losing weight that could burnish their wonder-product reputation?Presenter Greg Foot is joined in the studio by Lynn to hear her story and do a deep-dive into the science alongside Professor of Molecular Neuroendocrinology at the University of Cambridge, Giles Yeo.At Sliced Bread we're hungry for your suggestions so we can keep making fresh batches! If you've seen an ad, trend or wonder product promising to make you happier, healthier or greener, email us at sliced.bread@bbc.co.uk OR send a voice note to our WhatsApp number, 07543 306807.RESEARCHER: PHIL SANSOM PRODUCERS: SIMON HOBAN AND GREG FOOT

SPONSORS: - Don't miss out on all the action this week at DraftKings! Download the DraftKings app today! Sign-up using https://dkng.co/bears or through my promo code BEARS. - Protect your family with life insurance from Ethos. Get up to $3 million in coverage in as little as 10 minutes at https://ethos.com/BEARS. Application times may vary. Rates may vary. - Sponsored by BetterHelp. BetterHelp makes it easy to get matched online with a qualified therapist. Sign up and get 10% off at https://BetterHelp.com/bears - Sign up for your one-dollar-per-month trial and start selling today at https://shopify.com/bears The OG Bears are back on this absolutely unhinged episode of 2 Bears, 1 Cave! Bert Kreischer and Tom Segura dive headfirst into VR porn disasters, accidental virtual orgies, and the terrifying realization that Oculus might actually be ending humanity. Bert recounts a weekend alone that spirals into nine virtual orgies, soul-stealing eye contact, and panic-induced controller fumbling in a pitch-black room. The Bears also unpack loneliness, online hate comments, incel psychology, and how social media gives angry dudes a place to scream just to feel noticed. From there, things somehow get deeper: wealth guilt, excess consumption, purging hundreds of shoes and jackets, Mounjaro weight loss, beating Jelly Roll in the next 2 Bears 5K, parenting chaos, friendship evolution, Jake Paul as a “god,” and why success is always part luck. Enjoy the Bears while they're here. https://www.instagram.com/stavvybaby2 https://www.instagram.com/chrisdcomedy/ 2 Bears, 1 Cave Ep. 323 https://tomsegura.com/tour https://www.bertbertbert.com/tour https://store.ymhstudios.com Gambling Problem? Call 1-800-GAMBLER. New York: call 8778- HOPENY or text HOPENY. Connecticut: call 888-789-7777 or visit https://CCPG.org. On behalf of Boot Hill Casino in Kansas. Wager tax pass-through may apply in Illinois. Twenty one plus in most states. Void in Ontario. Restrictions apply. Bet must win to receive Bonus Bets which expire in 7 days. Minimum odds required. For additional terms and responsible gaming resources, see https://DKNG.co/audio Limited time offer. Chapters 00:00:00 - Intro 00:00:14 - Bert's First Threesome 00:05:58 - Mean Comments 00:13:05 - Hanging With The Kids During Christmas 00:30:02 - Stroke Of Luck 00:34:11 - Excess & Purging Stuff 00:44:05 - Weight Loss, Mounjaro & Jelly Roll 00:55:15 - Jake Paul Is A God? 01:01:01 - Wrap Up Learn more about your ad choices. Visit megaphone.fm/adchoices

✨ The GLP-1 Circle Membership is opening the doors soon, available for all GLP-1 users, it's your hub for dietitian/personal trainer support on your GLP-1 journey for only $99/month. Get first dibs on membership spots here: Join the waitlist

Ein feministisches 2026 – das wünschen wir uns und euch allen. Und direkt zum Jahresbeginn lohnt es sich, die feministische Brille aufzusetzen und einen der verbreitetsten Neujahrvorsätze (erneut) unter die Lupe zu nehmen: Abnehmen. Wir haben schon einmal über Diet Culture und Körperbilder gesprochen. Allerdings war das, bevor Ozempic und Co. den medialen Raum betreten haben. Inzwischen sind Abnehmspritzen omnipräsent und gelten als „Gamechanger“.Zu Gast sind die Psychologin Dr. Julia Tanck und die Autorin und Aktivistin Bobby Herrmann-Thurner. Von den beiden wollten wir wissen: Was macht die Verfügbarkeit, was macht auch der Konsum der Abnehmspritzen – zum Beispiel durch Prominente und auf Social Media – was macht das mit einem? Also psychisch? Mit dem Körperbild? Und welche Auswirkungen hat die Omnipräsenz von Abnehmspritzen auf ihre Arbeit?Artikel, die Ozempic, Wegovy, Mounjaro und Co. abfeiern, Influencer*innen und Promis, die ihre Abnehmgeschichte mit dem Zeug erzählen – davon gibt es genug. Was es unserer Meinung nach aber zu wenig gibt, das ist ein kritischer Blick, der die gesellschaftlichen Folgen, aber auch die individuellen psychologischen Folgen klar benennt. Und so viel vorweg: In Sachen Gewichtsdiskriminierung ist Ozempic wirklich keine Hilfe, wirklich kein „Gamechanger“ – eher im Gegenteil.Danke an alle, die den Lila Podcast unterstützenHelft uns, damit unsere Arbeit fair bezahlt werden kann! Alle Infos darüber, wie ihr den Lila Podcast supporten könnt, haben wir für euch hier gesammelt.Aktuelle Werbepartner und weitere Infos zum Podcast.Links und HinweiseTagesschau zu Ozempic 2023 Web Archive / EMA: OzempicYoutube / MAITHINX: Abnehmspritzen wissenschaftlich geprüftBobby Herrmann-Thurner / Kremayr & Scheriau: Fat Business Dr. Julia Tanck / Penguin: UnfilteredHealthline: Ozempic may not workGuardian: People who stop taking weight-loss jabs regain weight in under two years, study revealsDLF: Italien führt Aktionstag gegen Body Shaming einYoutube / ARD team.recheche: Wer profitiert vom Abnehm-Hype?Weitere Lila-Folge zum ThemaF*ck Diet Culture: Wie wir Frieden mit unserem Gewicht machen – mit RezoWeiß, schlank, männlich: Warum Sport inklusiver werden muss – mit Ireti Amojo und Sophie SchwarzTranskriptWir freuen uns sehr, euch ein Transkript zur Sendung zur Verfügung stellen zu können. Es wurde automatisch erstellt. Ihr findet es auf unserer Website. Hosted on Acast. See acast.com/privacy for more information.

One of the sure-thing top stories of 2026 will be GLP1s, but will we see more studies and even approval for treating type 1 with these medications? We're talking about Ozempic, Mounjaro and the next versions like Retatrutide - that are just around the corner. I'm talking to  Dr. Cecelia Lo Wong, a diabetologist at the University of Colorado whose been on the front lines of this conversation for years,  including serving on FDA advisory committees. This is a wide ranging interview - we also talk about the growing needs of older adults with type 1 diabetes, how kidney and cardiovascular risk guidelines are evolving, and why managing diabetes in the hospital can still be such a challenge. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. This week's Community Commercial is from Lisa Katzenburg, the author of "It Belongs to the World," a children's book version of the story of Frederick Banting and the discovery of insulin. Learn more about this book here Announcing Community Commericals! Learn how to get your message on the show here. Learn more about  studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Learn more about  Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com 

New Year not so new podcast! The Podgang kicks it off by laugh crying at the Venezuela situation, catch up on all things holiday and new year, mourn the loss of the 8×10 and more on the front half. Then, of course, the Stranger Things finale and Heated Rivalry is discussed! 2026! Discord: https://discord.gg/ntcQjmWJZW

In this episode, Gianna Beasley welcomes listeners to 2026 and discusses the importance of setting health goals for the new year. She outlines a roadmap for success on a GLP-1 journey, emphasizing the need for reflection, refocusing, consistency, and celebrating progress. The conversation is structured around four phases that guide listeners through their health journey, encouraging self-awareness and sustainable habits.

This week, Bunnie Xo sits down with comedy powerhouse Bert Kreischer for a wildly unfiltered conversation that goes everywhere—and then some. Bert opens up about his recent health and weight-loss journey, including experimenting with Mounjaro, peptides, and GLP-based treatments, along with the very real (and very graphic) side effects no one warns you about.The two also dive deep into mental health, sharing candid experiences with OCD, anxiety, medication, and exposure therapy. Bert breaks down his long-standing rituals, flying anxieties, and the routines he's stuck to for years, while both reflect on how vulnerability, social media, and public scrutiny impact their lives behind the scenes.Of course, it wouldn't be a Bert episode without stories about marriage, intimacy, past relationships, marijuana, and the evolution of his comedy career—from early fame to what's next, including a new Netflix special on the horizon. They also touch on family dynamics, reality TV hypotheticals, and Bert's upcoming Netflix series, The Legend of Bert, premiering January 22.Equal parts hilarious, honest, and unexpectedly heartfelt—this episode pulls back the curtain on fame, fear, and figuring it out in real time.Bert Kreischer: WebsiteWatch Full Episodes & More: YouTubeSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The US will "run" Venezuela until a "safe, proper and judicious transition" can be ensured, Donald Trump has said, after US strikes led to the capture of the Latin American country's president and his rendition to New York.What happens next in Venezuela? There's been celebration and condemnation of America's intervention. We'll hear from in Caracas and also the Colombia-Venezuela border.Also in the programme: We also hear from a former Trump insider who worked with him on Venezuela, ask a leading international criminal lawyer about the legality of the situation; and we'll hear about weight-loss drugs such as Ozempic, Mounjaro and Wegovy.(Photo shows Venezuela's President Nicolas Maduro at the offices of the U.S. Drug Enforcement Administration (DEA) in New York. Credit: White House's Rapid Response 47 account on X.com)

En el Radar Empresarial de esta jornada ponemos el foco en el negocio de los medicamentos para perder peso en Asia, un mercado que ha despertado un fuerte interés entre las grandes farmacéuticas. Novo Nordisk y Eli Lilly han identificado a China como un territorio clave para su expansión y ya han comenzado a mover ficha. Ambas compañías han decidido reducir de forma significativa el precio de sus tratamientos adelgazantes en el país con vistas al próximo año. En el caso de la empresa danesa, el coste de Wegovy se ha recortado casi a la mitad, mientras que la multinacional estadounidense ha lanzado Mounjaro por 445 yuanes, muy por debajo de los más de 2.000 que costaba antes. Los cambios en los hábitos sociales han convertido a China en un mercado enorme, impulsado por el crecimiento de la clase media y una dieta cada vez más calórica. Este contexto ha provocado un aumento sostenido del sobrepeso y la obesidad. Las estimaciones apuntan a que en 2030 más del 65% de la población china podría sufrir alguno de estos problemas. Ante este escenario, también han surgido iniciativas locales para desarrollar fármacos propios, como Mazdutide, una inyección creada por Innovent Biologics junto a Eli Lilly China, con pérdidas de peso cercanas al 15% tras 48 semanas. El desafío sanitario no se limita a Asia y también es prioritario en Estados Unidos, donde la obesidad y la diabetes ocupan un lugar central en la agenda pública. China, de hecho, es el país con más personas con diabetes: en 2024 se contabilizaban 148 millones de adultos, según la International Diabetes Federation. Por ello, firmas globales y competidores locales compiten por el liderazgo, mientras Novo Nordisk y Eli Lilly refuerzan sus vínculos con las autoridades chinas e impulsan nuevas inversiones estratégicas. Este acercamiento busca asegurar presencia a largo plazo y apoyar los objetivos del plan China Saludable 2030 oficial nacional.

Ozempic. Wegovy. Mounjaro. A few years ago, these were diabetes medications. Today, they're the hottest weight loss trend on the planet.I understand the pull. After decades of failed diets and shame spirals, someone hands you a needle and says, “This will finally work.” Of course you're tempted.But what happens when you stop? What message does it send about your body? And why does the weight almost always come back?In this episode, I'm breaking down the injection epidemic—not to shame anyone, but to ask the question nobody's asking: If the thermostat never changes, what exactly did the needle fix?In this episode:* Why people are fighting for weight loss prescriptions* The side effects nobody talks about* The message the needle sends: “Your body is broken”* Why weight returns when the injections stop* The thermostat metaphor—and why chemistry can't override identity This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.theweighout.net

Feeling stuck? If your GLP-1 weight loss has slowed down or stopped, you're not alone and it does not mean the medication stopped working. In this episode, Gianna walks you step-by-step through her checklist for stalls, which she uses to help GLP-1 clients restart progress without panic, restriction, or jumping doses.Listen to learn how to fuel properly, protect your metabolism, check your consistency, and adjust habits so your results return- calmly and confidently. ✨ The GLP-1 Circle Membership is opening the doors soon, available for all GLP-1 users, it's your hub for dietitian/personal trainer support on your GLP-1 journey for only $99/month. Get first dibs on membership spots here: Join the waitlist

In this episode, I explain how weight loss drugs like Ozempic and Mounjaro work, why they can cause muscle loss and weight regain, and what you must do with strength training, protein, and habits to lose weight sustainably.   Chapters:  00:06 Weight Loss Drugs and Aging Risk 02:17 Episode Overview 02:44 Weight Loss Drug Boom 05:39 How GLP-1 Drugs Work 06:31 Do Injections Work? 07:01 What Drugs Don't Do 08:50 Who They're For 09:49 Why Weight Is Regained 11:10 Identity and Long-Term Results 11:59 Final Verdict on Mounjaro and Ozempic   Next steps: 1) Book a 1-1 strategy session with my team to find out more: https://www.rntfitness.com/applynow  2) Take our free transformation quiz: https://www.rntfitness.com/transform Follow RNT Fitness: Website - http://www.rntfitness.com LinkedIn - https://uk.linkedin.com/company/rnt-fitness Instagram - http://www.instagram.com/rnt_fitness   Follow Akash: LinkedIn - https://uk.linkedin.com/in/akash-vaghela Instagram - http://www.instagram.com/akashvaghela

Share your guest suggestions hereMail - connect@beerbiceps.comLink - https://forms.gle/aoMHY9EE3Cg3Tqdx9Check out BeerBiceps SkillHouse's YouTube 1O1 Course - https://youtube.beerbicepsskillhouse.in/youtube-101BeerBiceps SkillHouse को Social Media पर Follow करे :-YouTube : https://www.youtube.com/channel/UC2-Y36TqZ5MH6N1cWpmsBRQ Instagram : https://www.instagram.com/beerbiceps_skillhouseWebsite : https://beerbicepsskillhouse.inFor any other queries EMAIL: support@beerbicepsskillhouse.comIn case of any payment-related issues, kindly write to support@tagmango.comLevel Supermind - Mind Performance App को Download करिए यहाँ से

GLP-1 drugs have become one of the most important developments in the pharmaceutical industry. With products like Ozempic, Wegovy, and Mounjaro in high demand, competition between drug makers is growing quickly. In this episode of Down to Business English, Skip Montreux and Dez Morgan get Down to Business with GLP-1 inhibitors — the drugs behind today's weight-loss boom. They explain who the main players are, including Novo Nordisk and Eli Lilly, and compare their leading products. Their discussion also looks at a major recent development: Pfizer's acquisition of biopharma startup Metsera, and why this deal could significantly change the market. Skip and Dez's conversation gives listeners a clear and practical introduction to competition and strategy in the pharmaceutical industry — while helping you improve your Business English. In this episode, you will learn: What GLP-1 drugs are and what they are used for. The main differences between Ozempic, Wegovy, Mounjaro, and Zepbound. Why Eli Lilly is gaining market share, especially in North America. How Pfizer's acquisition could affect future weight-loss treatments. Do you like what you hear? Become a D2B Member today for to access to our -- NEW!!!-- interactive audio scripts, PDF Audio Script Library, Bonus Vocabulary episodes, and D2B Member-only episodes. Visit d2benglish.com/membership for more information. Follow Down to Business English on Apple podcasts, rate the show, and leave a comment. Contact Skip, Dez, and Samantha at downtobusinessenglish@gmail.com Follow Skip & Dez Skip Montreux on Linkedin Skip Montreux on Instagram Skip Montreux on Twitter Skip Montreux on Facebook Dez Morgan on Twitter RSS Feed

What happens when a medication designed to help you lose weight also changes what brings you pleasure?In this solo episode, I'm doing a deep dive into what nobody's discussing about GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) and what they do to your sex life.These medications have been absolutely transformational for metabolic disease, obesity, and cardiovascular health. But they don't just work on your gut and pancreas they work centrally in your brain, in your reward pathways, in your pleasure centers.I'm sharing stories from my practice: the glamorous patient who suddenly didn't want to shop anymore. The wine connoisseur who lost interest in drinking. The foodies who can't stand restaurants. And yes, the patients whose sexual desire completely disappeared because their brain stopped experiencing reward the same way.Highlights:Why GLP-1 medications are actually anti-inflammatory powerhouses (and what that means for PCOS, endometriosis, even PGAD).How these drugs modulate dopamine and serotonin the same pathways that control sexual desire.Why improving body image doesn't always improve sexual function (the biopsychosocial model).The emerging science on GLP-1s reducing alcohol cravings, substance use, and compulsive behaviors.What SHBG changes mean for your free testosterone and libido.Why your brain doesn't compartmentalize pleasure food, shopping, alcohol, and sex all use the same reward circuits.The informed consent conversation every doctor should be having (but isn't).If you're on a GLP-1 medication or considering starting one, ask your doctor about how it might affect what brings you pleasure including sex. With great power comes great responsibility, and sexual health is health. Period.Get in Touch with Me:WebsiteInstagramYoutubeSubstackMentioned in this episode:GSM CollectiveThe GSM Collective - Chicago Boutique concierge gynecology practice Led by Dr. Sameena Rahman, specialist in sexual medicine & menopause Unrushed appointments in a beautiful, private setting Personalized care for women's health, hormones, and pelvic floor issues Multiple membership options available Ready for personalized women's healthcare? Visit our Chicago office today. GSM Collective

Howdy Hello and welcome to "Phat Love Talk"! I'm your host, Phat Love, and I'll be taking you on a journey through news and media I find interesting! TV Shows and Movies you should be watching, Sports conversations, Books I enjoyed reading and even some personal topics like my journey with weight loss on Mounjaro, Mental Health and living with Anxiety, Depression and ADHD. Be sure to check out my brother podcast, "AlphaPhenomenon Gaming Podcast", for all future gaming episodes. This ones for me, care to take a seat and listen?

durée : 00:02:54 - L'Humeur du matin par Guillaume Erner - par : Guillaume Erner - Je suis resté songeur devant cette couverture de L'Express. La millième, sans doute, consacrée aux médicaments du XXIᵉ siècle : Ozempic, Mounjaro, et toute cette pharmacopée miracle censée nous faire fondre. - réalisation : Félicie Faugère

What No One Tells You About Life After GLP-1 Meds GLP-1 medications like Ozempic, Wegovy, and Mounjaro have changed the game for weight loss—but what happens when the prescription ends and you need a plan? This week, I'm joined by Dr. Jim Hill, leading obesity researcher and architect of the National Weight Control Registry, to uncover what really happens after GLP-1s—and how to maintain your results without spiraling into regain. We'll explore the three types of weight regain, what makes maintenance so different from weight loss, and why your body is capable of mimicking GLP-1 effects naturally—if you know how to support it. Whether you're on these meds now, thinking of stopping, or just want to protect your progress, this is a must-listen.

Can you get rhabdomyolysis (rhabdo) from taking GLP-1 medications like Ozempic, Wegovy, and Mounjaro(tirzepatide)? Here are the reports of people getting rhabdo after taking these medications, including how much they took, how high their creatine kinase level were, and what happened. Rhabdo after taking glucagon-like peptides appears to be rare but this is still a side effect people should be aware of. View the video below to see the reports yourself.Referencehttps://youtu.be/NlLTIsXJ860 Read My Rhabdo BookAmazon https://amzn.to/4aRPnu4 (affilate link) Consultations https://supplementclarity.com/private-consultations/  Connect With MeaffiliateSupplementClarity.comYouTubeTiktok   About  I've been sorting nutrition facts from fiction since the 1990s and helping people understand dietary supplements, using clinical research as my litmus test. I am unbiased. I analyze the research so you don't have to.  I wrote the first book about exercise-induced rhabdomyolysis.I have an MS in exercise science and a BS in biology & chemistry.   Disclaimer Episodes are for information only. I'm NOT a medical doctor. NO medical advice is given or implied. ALWAYS consult your physician for the best health advice for you. I participate in theAmazon Associates program which means if you click on a link to amazon and make a purchase, I may make a small commission at no extra cost to you.

Send a Text Message. Please include your name and email so we can answer you! Please note, this does not subscribe you to our email list, it's just to answer if you have a questions for us. This week's Friday Five tackles a question many women quietly wonder about: “What should I expect if I restart Mounjaro after pregnancy and breastfeeding?”Whether you paused your GLP-1 for pregnancy, breastfeeding, or simply life circumstances, coming back to it after many months brings up a lot of unknowns. In this episode, I break down what typically happens, what we actually know from emerging research, and most importantly—why postpartum women need close, compassionate medical support.Inside the episode, we explore:1. What current guidelines say about GLP-1s, pregnancy, and breastfeedingThe traditional recommendation is stopping GLP-1s two months before trying to conceive and waiting until you're done breastfeeding to restart. But I also share a recent small study looking at semaglutide and its transfer into breast milk—and what that means (and doesn't mean) for real-life decisions.2. Why restarting after long-term use often looks differentIf you were previously on Mounjaro for 6–24 months, your body typically:tolerates the medication more easilycan often titrate up more quicklyexperiences fewer early side effects Some of this is physiologic, some behavioral—because you've already learned hydration, fiber strategies, and the day-after-injection do's and don'ts.3. The postpartum period is the “fourth trimester”—and it changes everythingExhaustion, unpredictable schedules, stress, hormones, sleep deprivation… postpartum is not just a season. It's a vulnerable season. This is why you should never “go cowboy alone” when restarting medication. A skilled clinician helps prevent:excessive restrictionmetabolic overwhelmworsening moodtipping into depression or anxietyextreme titration that backfires4. How ongoing support during pregnancy impacts your restartI share examples from my own clinic: Some women stay with me through pregnancy—not for weight loss, but for structure, nutrition support, and a stable relationship with food. Those women often find it much easier to restart postpartum because they never disconnected from caring for their bodies.5. The good news: most women feel relief when they restartOnce medically cleared and supported, many women say:their appetite becomes manageable againtheir mental load decreasestheir urges and cravings quiet downthey finally feel like they have helpAnd that's the whole point: to feel supported, not stressed.If you're in this season, I'm rooting for both your health and your baby's health. Postpartum is not a time to go it alone, and you deserve expert guidance every step of the way.I hope this episode gives you clarity, comfort, All of the information on this podcast is for general informational purposes only. Please talk to your physician and medical team about what is right for you. No medical advice is being on this podcast. If you live in Indiana or Illinois and want to work with doctor Matthea Rentea, you can find out more on www.RenteaClinic.com Health is the best gift you can give. Select ‘Give as a gift' at checkout to share one of our programs with someone you love. Explore the details here.Support the show

You've seen it all over social media. Everyone's talking about GLP-1's. Maybe you've heard the brand names—Ozempic, Wegovy, Mounjaro—and wondered, "What exactly is this, and why are so many women suddenly using it?" If you're in perimenopause and noticing weight gain despite doing everything "right," battling constant cravings, or feeling like your body is working against you... this episode is for you.Dr. Katashia is back on the podcast to break down exactly what GLP-1's are, how they work, and why they might be a game-changing tool for women navigating the hormonal chaos of midlife. She shares her own experience using them at 48, the side effects you need to know about, and the critical steps to take before you even consider starting. This isn't about taking shortcuts—it's about understanding your options and finally getting the support your body needs during this transition.In this episode we explore:The real purpose of your inner autumn — and how ignoring it creates hormone chaosWhat happens when you stop pushing through PMS and start listening to your bodyHow I cycle sync my entire business with the inner seasonsA behind-the-scenes look at my 2025 autumnTune in next week were we dive into Part 2 of this conversation.Resources:Dr Katashia's Website - drkatashia.comFollow Dr. Katashia on Instagram: @drkatashiaCheck her out on Facebook: Dr. Katashia Wellness CollectiveJoin my Hormone Unfiltered NewsletterAbout KateKate Nguy is the founder of Shee Revival and a Certified Hormone Health Practitioner and Cycle-Syncing Strategist who helps busy women in their 30s and 40s balance their hormones and reclaim their energy. Specializing in the hormonal ups and downs of midlife—from PMS and perimenopause to burnout and cortisol overload—Kate guides women to feel at home in their bodies and live in sync with their natural cycles.. Through cycle syncing, hormone hacks, and nervous system regulation, Kate empowers women to rebalance their hormones, reconnect to their bodies, and revive the vibrant, grounded version of themselves underneath the overwhelm.Tune in now and join the movement toward better hormone health!Follow me @hormoneswithkate on Instagram for more insights, tips, and support!

O Mounjaro, medicamento contra diabete utilizado para auxiliar na perda de peso, se transformou no queridinho da classe política em Brasília. Reportagem do UOL mostrou que, no caso do senador Davi Alcolumbre (União Brasil-AP), a origem do medicamento é um empresário foragido da Justiça por envolvimento em um esquema de fraude em combustíveis e lavagem de dinheiro. O empresário é Roberto Augusto Leme da Silva, conhecido como Beto Louco, e está foragido, entre outras coisas, por suspeita de ligação com o Primeiro Comando da Capital, o PCC, maior facção do Brasil. Ele nega. É sobre esse presente de um foragido ao atual presidente do Senado que José Roberto Toledo conversa com o repórter Fabio Serapião, autor da reportagem, no novo episódio do podcast UOL Prime. Nota da defesa: A defesa desconhece os fatos objeto do questionamento. A respeito da inverídica relação de Roberto Leme e Mohamad Mourad com o PCC, são manifestamente equivocadas quaisquer afirmações nesse sentido. Não existe nenhuma evidência probatória que dê liame a essa falsa alegação. #uolprime #PodcastUOLPrime

Doctor Mau Informa ®️#drmauinforma 

Send us a textIn this next “Best of 2025” series, I'm bringing back a popular episode featuring my amazing husband, Dr. Taylor Brueseke. Together, we break down Wegovy, Ozempic, and Mounjaro to clear up common misconceptions. Dr. Brueseke explains how these medications work, what they're intended for, and the potential side effects, while I share my personal experience to give you a real-life perspective on using them. Whether you're a healthcare professional, someone navigating your own health journey, or simply curious, this episode will help you better understand these treatments. Let's sort through the confusion and get to the truth about Wegovy, Ozempic, and Mounjaro. Let's dive in!Find show notes at bicepsafterbabies.com/395Follow me on Instagram and Tiktok!Links:Episode 317: I Was Wrong About Wegovy, Ozempic, and Mounjaro with Dr. Taylor Brueseke

Book a FREE functional health discovery call HERE. If you've been hearing the buzz about Ozempic, Wegovy, Mounjaro, or other GLP-1/GIP medications, you're not alone. But there's so much more to this conversation than weight loss. In this episode, Tanya breaks down the real science behind GLP-1 receptor agonists — what they are, how long they've been around, and the growing research that shows benefits far beyond the scale. From heart and kidney protection to inflammation reduction and body composition support, Tanya explains what midlife women need to know before jumping on the bandwagon. She also shares her personal journey exploring micro-dosing peptides (including tirzepatide and NAD+) — what she's learning, what's working, and how she's helping women make informed, safe, and personalized decisions through trusted telemedicine partnerships. Whether you're considering GLP-1s, curious about peptides, or simply trying to build energy and longevity in midlife, this episode will help you understand the research, the real benefits, and the importance of building your health on solid foundations. You'll Learn: What GLP-1 receptor agonists are and how they work in the body The long-term research behind GLP-1s — including heart, kidney, and liver health benefits What “micro-dosing” really means (and what we don't yet know) How peptides like tirzepatide and NAD+ may support energy, inflammation, and recovery Why foundational health habits — nutrition, muscle, rest, stress regulation — matter more than any injection or supplement Practical, real-world takeaways for midlife women seeking sustainable health and vitality Disclaimer: This episode is for educational purposes only and should not be taken as medical advice. Always consult with a qualified healthcare provider before beginning or changing any health protocol or medication.   I hope this episode blesses you! Xoxo, Tanya Episode Resources: Episode Catalog   My trusted Supplement Dispensary: Aligned Vitality Fullscript Dispensary My trusted Telehealth Peptide Provider:  EllieMD_Tanya Engesether *I do get a small commission when you use one of the above affiliate links. 3 Ways To Connect With Me: 1️⃣COACHING: Are you READY to Lead Well, Live Well and BE Well? Book a FREE discovery call with me to find out more about functional health coaching. It's the accountability and guidance you need to reclaim your health and happiness! ➡︎ https://alignedvitalityhealth.com/coaching   2️⃣ FACEBOOK: Become part of our Supportive Facebook Group. Connect, share, and learn with others navigating life and leadership ➡︎ https://alignedvitalityhealth.com/community   3️⃣ CONTACT: Leave me a question or comment ➡︎ https://alignedvitalityhealth.com/contact   "Yes! Finally, a podcast helping others become the thriving leaders they're meant to be outside of hustle-culture! This is an amazing resource! Thank you so much for sharing and helping us become Spirit-driven, peaceful leaders!"    If you can relate, please consider rating and reviewing my show! It helps me reach more people – just like you – to help them change their future. Don't forget to follow the show so you don't miss any episodes! And, if you're feeling really generous, I'd be SO honored if you would share this podcast with someone.   Click here to view our privacy policy.   Reminder:  The information you hear on this show is not meant to diagnose, treat, cure or prevent disease.  It is for educational purposes only. Always consult with your own health practitioner before you make any changes to your health.

Episode Timeline & Main Topics 00:00 — Opening & Community Update • First week doing the podcast fully live thanks to the On The Pen community • Overview of why this week's news is a major turning point in obesity medicine 02:30 — Introducing the “One-and-Done” Obesity Drug (Wave Life Sciences) • WVE-007 early data drops • Why this therapy is unlike GLP-1s or any nutrient-stimulated hormone • Fat loss results and lean-mass increase 06:30 — How Wave-007 Works: INHBE Gene Silencing • Mechanism behind visceral fat reduction • Why this shifts the field toward “quality of weight loss” 09:15 — Why Lean-Mass Preservation Matters • Current GLP-1 medications and muscle loss • Why women dominate trial enrollment and the larger implications • Medicare patients and the coming wave of GLP-1 coverage 13:45 — The Future of Maintenance Therapies • Fractyl Health Revita results • Lilly's orforglipron maintenance design • Why “holding the line” after GLP-1 therapy is the next major category 17:30 — Amylin Agonists: Cagrelintide vs. Eloralintide • Novo's delays and the strategy behind them • Lilly's surprising phase 2 results (up to 20% weight loss) • Combination therapies with tirzepatide or retatrutide 22:30 — FDA Pipeline Acceleration • Potential removal of traditional phase 3 trials • How this speeds up the arrival of next-generation therapies 24:15 — Oral GLP-1 Small Molecules (Structure Therapeutics) • Alaniglipron data and the stock surge • Comparisons to orforglipron and past failures like denuglipron • Why Dave remains skeptical 28:40 — Sponsor Break: Shed & Shapa • Access, coaching, and patient support • Using a numberless scale to build a healthier relationship with weight tracking 31:10 — Counterfeit Ozempic Warning • New fake lot discovered in U.S. pharmacies • How to identify counterfeit pens • Why this should be a national headline • The broader question of drug supply-chain vulnerability 36:00 — Closing Thoughts on the Future of Obesity Medicine • Moving from “more weight loss” to “better weight loss” • Why the field is closer than ever to reshaping obesity as a disease • Gratitude for the community making full-time coverage possible Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor answer listener questions about BMI cutoffs, weight cycling, metabolic adaptation, trauma, GLP-1 differences, and why some people gain weight on ultra-low calories. Dr. Cooper explains what's really happening inside the metabolic system and why individualized treatment—not dieting—creates sustainable change.Key Questions AnsweredIf my BMI doesn't “qualify” for GLP-1s, is Naltrexone + Bupropion helpful—and what labs matter first?Does being overweight always indicate metabolic dysfunction, and why are U.S. rates so high?If diets damage metabolism, what do you do when you're already 80 pounds overweight?How long does it take for leptin and ghrelin to stabilize with mechanical eating?How can someone gain weight on 1,200 calories/day?After sleeve gastrectomy, how do you eat enough while on a GLP-1?Is set point theory real—and how does the melanocortin pathway influence it?If obesity runs in my family, will I need meds like Zepbound for life?How do trauma and stress alter long-term metabolic health?Can GLP-1s offset weight gain from steroids, mood meds, or hormones?Why might Ozempic work well while Mounjaro causes weight gain?Key Takeaways1. BMI rules don't reflect metabolic truth.A mid-20s BMI can still mask significant dysfunction, especially with weight cycling.2. Weight cycling is metabolically stressful.Repeated losses/regains increase visceral fat, insulin abnormalities, and cardiovascular risk.3. Obesity is a multi-hormonal disease.Most people need pharmacology plus sleep, fueling, and movement—not restrictive dieting.4. Metabolic adaptation is powerful.Under-fueling lowers thyroid output, suppresses fat-burning, and slows metabolism dramatically.5. After bariatric surgery or on GLP-1s, frequency matters.Frequent, nutrient-dense snacks protect muscle, metabolism, and energy.6. Set point changes with better signaling.GLP-1s and related therapies help the brain accurately detect weight and lower the defended level.7. Genetics often mean lifelong support.Family patterns of obesity usually indicate long-term need for metabolic medication.8. Trauma amplifies metabolic risk.Childhood trauma disrupts IGF-1, sleep, stress hormones, insulin, leptin, and ghrelin.9. Medications can cause weight gain—GLP-1s can help counteract it.Steroids, mood meds, hormonal agents, and more can be metabolically unfriendly.10. “Newer” isn't always better.Some people respond poorly to the GIP component in Mounjaro/Zepbound. Individual physiology rules.Dr. Cooper's Actionable TipsRequest deeper evaluation: DEXA, visceral fat, fasting insulin/glucose, leptin, reproductive hormones.Stop restrictive dieting permanently—mechanical eating protects metabolic stability.Work with a fueling-focused dietitian (often ED-trained).Review your medication list for drugs known to cause weight gain.Don't switch GLP-1s or chase higher doses if your current regimen works.Notable Quote“Obesity isn't a willpower problem. It's a metabolic disease, and when the underlying system is supported, the body finally has permission to change.” — Dr. Emily CooperLinks & ResourcesPodcast Home: Fat Science Podcast WebsiteSubmit a Show Question: questions@fatsciencepodcast.com or dr.c@fatsciencepodcast.comDr. Emily Cooper on LinkedInMark Wright on LinkedInAndrea Taylor on InstagramFat Science is your source for breaking diet myths and advancing the science of true metabolic health. No diets, no agendas—just science that makes you feel better. The show is informational only and does not constitute medical advice.

✨ The GLP-1 Circle Membership is opening the doors soon, available for all GLP-1 users, it's your hub for dietitian/personal trainer support on your GLP-1 journey for only $99/month. Get first dibs on membership spots here: Join the waitlist

The cozy, magical season is here! Leggings, sweaters, cookies, hibernation mode. But this can also become the season where we disconnect from our bodies without even realizing it.In this episode, I'm sharing a truth we don't talk about enough:✨ The longer you hide in leggings and oversized sweatshirts, the longer you stay in denial about where you really are physically and emotionally. ✨ Getting dressed, putting on makeup, and wearing a real outfit isn't about vanity… it's about awareness, identity, and showing up for yourself. ✨ And what I don't want is for you to “wake up” in spring only to realize nothing fits and you don't recognize yourself.Let's talk about how you can stay connected, confident, and present with yourself even during cozy season so you don't lose yourself in the process.

Convidados: Bruno Geloneze, endocrinologista e pesquisador da Unicamp, e Henderson Fürst, diretor da Sociedade Brasileira de Bioética. Na semana passada, uma operação da Polícia Federal mirou um esquema ilegal de produção de canetas usadas para emagrecimento. No Brasil, apenas um laboratório tem autorização para vender a Tirzepatida (princípio ativo do Mounjaro) em larga escala. Mas o remédio pode ser feito em farmácias manipuladas, para que médicos ajustem a dose exata para pacientes com necessidades específicas. No esquema investigado pela PF, o médico produzia Tirzepatida em larga escala, sem seguir as regras estabelecidas pela Anvisa. A alta demanda por canetas emagrecedoras manipuladas tem explicação: no caso deste tipo de medicamento, o preço chega a ser metade do valor dos remédios originais, cujas patentes estão em poder de grandes fabricantes. Neste episódio, Victor Boyadjian conversa com o médico endocrinologista Bruno Geloneze e com o advogado Henderson Fürst. Especialista em endocrinologia e metabologia e pesquisador do Centro de Pesquisa em Obesidade e Comorbidades da Unicamp, Geloneze explica quais as diferenças entre os remédios feitos em laboratório e os manipulados. Ele detalha os riscos do uso de canetas emagrecedoras sem saber sua procedência exata e é taxativo: o barato pode sair caro. Diretor da Sociedade Brasileira de Bioética, Henderson fala sobre como um julgamento no Superior Tribunal de Justiça (STJ) nas próximas semanas pode mudar o status das patentes das canetas emagrecedoras no Brasil. Ex-presidente da Comissão de Bioética da OAB, Henderson fala quais seriam os impactos do fim das patentes deste tipo de medicamento e explica quais regras da Anvisa para produção e consumo das canetas estão em vigor.

Both the Lions and Michigan lose, Eli Zaret joins us as MSU hires Pat Fitzgerald, Tara Reid is a mess, Me-Me-Meghan Markle is a menace, Try Guy Ned Fulmer turns into Cry Guy, and Akaash Singh's wife continues her reign of terror. Eli Zaret joins the show as Michigan falls to the Ohio State Buckeyes, CFB coaching carousel, too much Tom Brady (and why you look different?), MSU's terrible attendance at Ford Field, Jonathan Smith blown OUT, Jordon Hudson at the pump, Michigan basketball wins the Players Era Festival, MSU wins the Fort Myers Tip-Off, the Detroit Lions lose on Thanksgiving, Aidan Hutchinson MIA, Frank Ragnow un-retires and then re-retires, the MLB Winter Meetings, another University of Georgia driving violation, and RIP Fuzzy “Jokester” Zoeller (nice joke, btw). Oh, and Donald Trump nailed a chip shot. The Lions suck, the season is probably over… but Jack White and Eminem rocked the Thanksgiving Halftime show. Drew breaks down the 10 most memorable Thanksgiving Day Halftime Shows. South Park crushed it once again. Ned Fulmer has had a rough time in entertainment recently… so now he turns to his Multiple Sclerosis diagnosis for views. Tara Reid vs YouTuber ‘Sean P'. She's looking great these days. She's totally single now. Why You Look Different?: Kelly Osbourne? Ariana Grande? Kim Mathers? Come out to the Lodge Friday night (9pm – 10pm) to hang with us and support Killer Cares. Amy Schumer is only posting pics of how hot she is thanks to Mounjaro. Hollywood Confidential used our show clips to bash Meghan Markle. Ha ha! She has an As Ever pop-up store at the Soho Home. She has been labeled the ‘Salmonella Sussex'. She'll do anything for a photo op. King Charles wants her to reconnect with Thomas. Akaash Singh's wife remains a human toilet. It's all about Jasleen. Turns out OnlyFans may be problematic for some girls. Jess Brolin is a slob and Drew thinks he looks like Brad Pitt. Gays Against Groomers vs Baltimore teacher James Stilipec. Breaking News: Pat Fitzgerald to MSU. Don't forget to grab your Drew Lane Show merch right here! If you'd like to help support the show… consider subscribing to our YouTube Channel, Facebook, Instagram and Twitter (Drew Lane, Marc Fellhauer, Trudi Daniels, Jim Bentley and BranDon).

Donate (no account necessary) | Subscribe (account required) Join Bryan Dean Wright, former CIA Operations Officer, as he dives into today's top stories shaping America and the world. In this Monday Headline Brief of The Wright Report, Bryan covers the nation's grief and anger after the Washington terror attack, the deepening crisis within America's immigration system, and President Trump's most sweeping border actions yet. He also examines the political backlash, the debate over assimilation, and the global pressures shaping events from Europe to Venezuela. America Mourns and Demands Answers: Staff Sgt. Andrew Wolfe remains in critical condition while Specialist Sarah Beckstrom is laid to rest after last week's terror attack in Washington. DHS confirmed the attacker, Rahmanullah Lakanwal, was a former CIA-backed Afghan Zero Unit fighter who was radicalized after arrival in the United States. Investigators say he drifted between Washington State, Arizona, and the East Coast with little oversight, revealing systemic vetting failures across multiple administrations.   Vetting Breakdown Exposed: Inspector General reports show that over two hundred thousand Afghans brought into the country during the 2021 evacuation were admitted with almost no reliable databases, poor ID verification, and limited interagency cooperation. None received continual vetting after entry. Bryan explains why "strict vetting" is a political myth and why U.S. systems remain unable to verify criminal history, ideology, or cultural fit for many migrants.   Trump Orders the Most Sweeping Immigration Freeze in Decades: The President has paused all asylum applications, halted Afghan visa processing, and instructed his team to permanently pause migration from Third World nations to reset the system. Green card and citizenship requests from nineteen countries are suspended. Trump is also considering the denaturalization of foreign-born citizens who fail loyalty or cultural compatibility standards. Legal scholars note that Section 212(f) of the Immigration and Nationality Act grants the President broad authority to take such steps.   Political Firestorm and Cultural Divide: Republicans and most Independents support a historic crackdown, while Democrats accuse Trump of racism and xenophobia. Some leaders, including Representative Jasmin Crockett and Representative Debbie Wasserman Schultz, blamed the National Guard deployments for the attack. Bryan argues that many progressive lawmakers reject assimilation because they reject the idea of American culture itself, pointing to recent examples in education, media, and politics.   College Degrees Lose Appeal: New polling shows only 33 percent of Americans believe a four-year degree is worth the cost. Interest in vocational training and maritime careers is rising as tuition increases outpace wages. Maritime academies report that graduates earn more than $200,000 a year after six months of work.   The Autopen Controversy: President Trump announced he is canceling all executive actions signed by Joe Biden through the autopen, citing concerns that Biden did not authorize their use. The Justice Department may soon bring cases that will force the Supreme Court to clarify the legality of autopen approvals.   Debate Over Unlawful Orders Heats Up: Reports claim Secretary of War Pete Hegseth ordered a second strike on a cartel boat. Hegseth denies it. Senator Mark Kelly suggested troops should rely on intuition when evaluating orders, which critics warn could lead to chaos and politicized discipline. The issue may shape U.S. operations in the Caribbean.   Global Flashpoints: Venezuela and Europe: Trump rejected demands from Venezuela's Nicolás Maduro for guaranteed amnesty and military control as part of an exit deal. Maduro may attempt a guerrilla resistance if forced out. In Europe, Islamist protests are disrupting Christmas markets in Belgium and Germany, where security costs have surged. France's populist movement is surging in polls as crime tied to migrants fuels public frustration. Portugal's populist party Chega is also now tied for first place in national polling.   Medical News: A major UK study finds that weight loss drugs like Mounjaro and Zepbound must be taken long-term to maintain results, with many patients regaining most of the weight after stopping treatment.   "And you shall know the truth, and the truth shall make you free." - John 8:32     Keywords: Washington DC terror attack Afghan Zero Unit, Rahmanullah Lakanwal vetting failure, Trump asylum freeze Section 212f, de-naturalization debate immigration reform, Jasmin Crockett Guard criticism, Debbie Wasserman Schultz Trump blame, college degree value drop vocational training, autopen Biden executive actions, Hegseth double tap allegation, Venezuela Maduro exit talks, Belgium Germany Christmas market threats, France National Rally Bardella, Portugal Chega Ventura, GLP-1 weight loss drug study UK

This week Kevin and PJ are feeling fragile as PJ's back is in bits after a yoga class and the lads realise it is probably a blessing they do not have periods because they would absolutely never shut up about it. For the theme they dive into GLP 1s, prompted by the rise of Ozempic and Mounjaro. They chat about their own relationships with their bodies, the way fat people are treated in society and how Irish mothers are far more likely to compliment you on losing five pounds than saving a life.For support around body image, eating disorders, or related concerns, visit BodyWhysSign up to the I'm Grand Mam Patreon for more stunning content ✨ Hosted on Acast. See acast.com/privacy for more information.